FABP4 has been shown to play a significant role in the development of insulin resistance, type 2 diabetes mellitus and atherosclerosis through its action at the interface of metabolic and inflammatory pathways in adipocytes and macrophages3–5. The gene discussed is FABP4; the disease is Insulin resistance.